Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50013130
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50511703(CHEMBL4454935)
Affinity DataIC50: 17nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562881(CHEMBL4746006)
Affinity DataIC50: 19nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562881(CHEMBL4746006)
Affinity DataIC50: 19nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562880(CHEMBL4740425)
Affinity DataIC50: 31nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562880(CHEMBL4740425)
Affinity DataIC50: 31nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562881(CHEMBL4746006)
Affinity DataIC50: 34nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562881(CHEMBL4746006)
Affinity DataIC50: 35nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562875(CHEMBL4745601)
Affinity DataIC50: 44nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562875(CHEMBL4745601)
Affinity DataIC50: 44nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562880(CHEMBL4740425)
Affinity DataIC50: 51nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562880(CHEMBL4740425)
Affinity DataIC50: 54nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50511703(CHEMBL4454935)
Affinity DataIC50: 59nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562874(CHEMBL4740681)
Affinity DataIC50: 63nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562874(CHEMBL4740681)
Affinity DataIC50: 63nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562878(CHEMBL4759950)
Affinity DataIC50: 67nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562878(CHEMBL4759950)
Affinity DataIC50: 99nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562879(CHEMBL4761907)
Affinity DataIC50: 100nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562879(CHEMBL4761907)
Affinity DataIC50: 100nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562875(CHEMBL4745601)
Affinity DataIC50: 120nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562875(CHEMBL4745601)
Affinity DataIC50: 120nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562879(CHEMBL4761907)
Affinity DataIC50: 280nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562879(CHEMBL4761907)
Affinity DataIC50: 280nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562877(CHEMBL4753425)
Affinity DataIC50: 330nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562874(CHEMBL4740681)
Affinity DataIC50: 1.40E+3nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562874(CHEMBL4740681)
Affinity DataIC50: 1.40E+3nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562876(CHEMBL4748544)
Affinity DataIC50: 2.10E+3nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562876(CHEMBL4748544)
Affinity DataIC50: 2.10E+3nMAssay Description:Binding affinity to RORgammat (unknown origin) in cell-free systemMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562877(CHEMBL4753425)
Affinity DataIC50: 2.50E+3nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562876(CHEMBL4748544)
Affinity DataIC50: 1.50E+4nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNuclear receptor ROR-gamma(Human)
Teijin Pharma

Curated by ChEMBL
LigandPNGBDBM50562876(CHEMBL4748544)
Affinity DataIC50: 1.50E+4nMAssay Description:Inverse agonist activity at GAL4-fused RORgammat (unknown origin) transfected in HEK293T cells assessed as inhibition of RORgammat driven transcripti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed